In this article MSFT Follow your favorite stocks CREATE FREE ACCOUNT The Cursor logo arranged on a smartphone in New Hyde Park, New York, US, on Thursday, Nov. 20, 2025. Gabby Jones | Bloomberg | Getty Images Cursor announced updates to its artificial intelligence coding agents on Tuesday as the startup works to fend off increasingly stiff competition from rivals like Anthropic , OpenAI and Micros...
In this article MSFT Follow your favorite stocks CREATE FREE ACCOUNT The Cursor logo arranged on a smartphone in New Hyde Park, New York, US, on Thursday, Nov. 20, 2025. Gabby Jones | Bloomberg | Getty Images Cursor announced updates to its artificial intelligence coding agents on Tuesday as the startup works to fend off increasingly stiff competition from rivals like Anthropic , OpenAI and Microsoft . The AI startup has to stay on the cutting edge to win new users and market share, and the company told CNBC that its updated agents push its capabilities to the next level. The startup's valuation has ballooned to $29.3 billion, and it said in November that it had crossed $1 billion in annualized revenue. Cursor was relatively early to the AI coding market, but other players have been quick to launch competing offerings. AI agents are tools that can complete tasks on behalf of a user, and they have exploded in popularity over the last year as model capabilities have improved. Some of the earliest adopters have been software developers, who are using agents from companies like Cursor to generate, edit and review code. Cursor's updated agents can test their own changes and record their work through videos, logs and screenshots, the company said. Users can trigger the agents from the web, Cursor's desktop app, on a mobile device, through the messaging platform Slack or on Microsoft's GitHub. The agents can also run in parallel with full development environments on their own virtual machines, which are cloud-based computers that behave just like a physical one. This means agents won't have to compete for resources locally on a developer's laptop or waste time onboarding, Cursor said. "Instead of having one to three things that you're doing at once that are running at the same time, you can have 10 or 20 of these things running," Alexi Robbins, co-head of engineering for asynchronous agents Cursor, told CNBC in an interview. "You can have really high throughput with this."...
Grail (NASDAQ: GRAL) stock rose by more than 16% by midday. The move follows a couple of days of brutal declines after the release of top-line results from its three-year, 142,000-person trial of its Galleri multi-cancer early detection (MCED) test with England's National Health Service. I discussed the stock's decline on the f irst day of trading after the release, and the market punished it agai...
Grail (NASDAQ: GRAL) stock rose by more than 16% by midday. The move follows a couple of days of brutal declines after the release of top-line results from its three-year, 142,000-person trial of its Galleri multi-cancer early detection (MCED) test with England's National Health Service. I discussed the stock's decline on the f irst day of trading after the release, and the market punished it again on Monday . However, let's focus on why the market may be optimistic about future developments. As a reminder, the primary endpoint of the trial (which it missed) was to achieve a statistical significant reduction in combined Stage III and Stage IV cancers across 12 deadly indications. Continue reading
The German government agreed to abolish a controversial ban on new gas and oil heating systems as Chancellor Friedrich Merz ’ conservatives rush to deliver on a key electoral promise. The heating law signed off by the previous government in 2023 sparked a public outcry as it required newly-installed heating systems to use at least 65% renewable energy. At the moment, almost 80% of Germany’s reside...
The German government agreed to abolish a controversial ban on new gas and oil heating systems as Chancellor Friedrich Merz ’ conservatives rush to deliver on a key electoral promise. The heating law signed off by the previous government in 2023 sparked a public outcry as it required newly-installed heating systems to use at least 65% renewable energy. At the moment, almost 80% of Germany’s residential buildings are estimated to rely on oil or gas heating. The 65% requirement has now been dropped, according to a jointly agreed policy paper from Merz’s center-right CDU/CSU bloc and its Social Democrat coalition partner. Instead, the coalition agreed to introduce a “green gas quota” which is meant to oblige gas suppliers to blend a growing share of renewable gases, such as biomethane or hydrogen, into heating systems. The new heating law will also not contain any provisions that make it mandatory to replace existing heating systems that are in good working order, according to the coalition paper. Ahead of last year’s elections, Merz’s conservatives had vowed to scrap the regulation and ease burdens for households, though they had to find a compromise with the Social Democrats, who were part of the coalition that originally introduced the controversial law. The latter had pushed for the 65% rule to remain, in line with the recommendations of Germany ’s Environment Agency. The uncertainty over heating rules has caused consumers to delay installations, with sales of heating systems dropping 12% last year to a 15-year low, the Federal Association of the German Heating Industry said earlier this month . The association of house owners said ahead of Tuesday’s decision that it supported making suppliers responsible for the provision of more renewable energy in heating, rather than consumers. At the same time, environmental organizations warned the introduction of a “green gas quota” would extend the life of fossil fuel heating systems.
⚽ Champions League updates from the 8pm GMT kick-offs ⚽ Live scores | Sign up for Football Daily | And mail Scott For the fourth time in the tie, Atleti go into the lead! Johnny Cardoso meets a half-hearted header on the edge of the Brugge D. He takes a touch before whipping a low shot into the bottom left. It wasn’t tight in the corner, and so once again Simon Mignolet may have done better, but i...
⚽ Champions League updates from the 8pm GMT kick-offs ⚽ Live scores | Sign up for Football Daily | And mail Scott For the fourth time in the tie, Atleti go into the lead! Johnny Cardoso meets a half-hearted header on the edge of the Brugge D. He takes a touch before whipping a low shot into the bottom left. It wasn’t tight in the corner, and so once again Simon Mignolet may have done better, but it was hit pretty sweetly nonetheless. For the completist, here are the team-sheets from Madrid. There were no changes during the first half … and none at the break either. The second half is underway at the Metropolitano. Continue reading...
Oil is holding near a seven-month high as investors await the next round of US-Iran talks. Prices have climbed this year on concerns about the potential fallout from a US strike on Iran, even as forecasts point to more oil supply than demand later this year. Baker Hughes Chief Executive Officer Lorenzo Simonelli joined Bloomberg Open Interest with his insights and how the company is benefitting fr...
Oil is holding near a seven-month high as investors await the next round of US-Iran talks. Prices have climbed this year on concerns about the potential fallout from a US strike on Iran, even as forecasts point to more oil supply than demand later this year. Baker Hughes Chief Executive Officer Lorenzo Simonelli joined Bloomberg Open Interest with his insights and how the company is benefitting from the AI data trade. (Source: Bloomberg)
DraftKings (NASDAQ: DKNG) is moving forward with a restructuring that could see it lay off a sizable portion of its workforce. In a recent note on the stock published by Citizens , the firm's analysts estimated that workforce reductions would come in at the lower end of the 2% to 15% range that has been the norm among tech companies recently. In the note, Citizens reiterated a market-outperform ra...
DraftKings (NASDAQ: DKNG) is moving forward with a restructuring that could see it lay off a sizable portion of its workforce. In a recent note on the stock published by Citizens , the firm's analysts estimated that workforce reductions would come in at the lower end of the 2% to 15% range that has been the norm among tech companies recently. In the note, Citizens reiterated a market-outperform rating on DraftKings stock and set a one-year price target of $38 per share. As of this writing, that target implies upside of roughly 72%. Image source: Getty Images. Continue reading
Telecom Italia SpA ’s board proposed an up to €400 million ($471 million) stock buyback and a 1-for-10 reverse stock split, moving to overhaul its equity profile after selling off assets. The board announced the company’s first share repurchase in years on Tuesday, linking it to proceeds from the sale of submarine cable unit Sparkle. Directors said the reverse split is aimed at attracting a broade...
Telecom Italia SpA ’s board proposed an up to €400 million ($471 million) stock buyback and a 1-for-10 reverse stock split, moving to overhaul its equity profile after selling off assets. The board announced the company’s first share repurchase in years on Tuesday, linking it to proceeds from the sale of submarine cable unit Sparkle. Directors said the reverse split is aimed at attracting a broader class of institutional investors, by reducing the number of shares outstanding and curbing price volatility. The moves, reported with preliminary annual results, mark a turning point for the former Italian phone monopoly, which is reshaping itself after last year’s sale of its fixed-line network to a KKR & Co. -led group and making other disposals to cut debt. With leverage down and stronger liquidity, management is seeking to balance financial discipline with renewed payouts. For all of 2025, Telecom Italia reported adjusted net debt of €6.85 billion after lease commitments, a reduction of €412 million year-on-year. In a statement, the company cited strong cash generation in the fourth quarter. Revenue for the year totaled €13.73 billion, while earnings before interest, taxes, depreciation and amortization after leasing costs reached €3.69 billion, in line with analysts’ estimates. In January, shareholders approved a long-delayed plan to convert the company’s savings shares into ordinary stock, a move that simplified the capital structure as Chief Executive Officer Pietro Labriola pushed through a series of measures to stabilize the company. Read More: Telecom Italia Investors Approve Overhaul of Share Structure Italy’s telecommunications market remains one of Europe’s most competitive, four mobile operators locked in a prolonged price war that has squeezed margins for years. Industry executives and investors expect further consolidation after a wave of deals, as operators seek scale and more rational pricing. Looking ahead, Telecom Italia forecast revenue growth of 2% t...
quantic69/iStock via Getty Images The last time I wrote an article on MoonLake Immunotherapeutics ( MLTX ), it was in a Seeking Alpha article entitled " MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest. " At that time, things were looking very good for the company because it was in the process of running the late-stage VELA program using its drug sonelokimab to treat...
quantic69/iStock via Getty Images The last time I wrote an article on MoonLake Immunotherapeutics ( MLTX ), it was in a Seeking Alpha article entitled " MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest. " At that time, things were looking very good for the company because it was in the process of running the late-stage VELA program using its drug sonelokimab to treat patients with hidradenitis suppurativa [HS]. Plus, there was a report that Merck ( MRK ) might have made a non-binding offer for the company , valuing it at around $3 billion. The stock has traded lower since then, especially since the company ran into a huge roadblock back in September of 2025. The problem stemmed from the fact that one of the two phase 3 studies it released at this time as part of this VELA program, VELA-2, had failed to achieve a statistically significant outcome for the treatment of patients with HS. This caused the stock to trade lower since then, and things looked bleak because of this. At that time I had a Strong Buy rating on the stock, but today I'm going to downgrade the stock to a Buy rating. The reason why is because despite the miss of the primary endpoint for the VELA-2 study, an FDA Type B meeting outcome went particularly well. What do I mean by this? In essence, during the meeting, the FDA stated that the company would be allowed to file a Biologics License Application [BLA] submission of sonelokimab for the treatment of patients with HS solely on the basis of the VELA-1, VELA-2, and MIRA trials. The bottom line is that the FDA stated that substantial evidence of effectiveness [SEE] could be possible without the need for additional clinical trials for this HS drug development program. To this end, MoonLake is still on track to submit a BLA of sonelokimab for HS in the 2nd half of 2026. Not only that, but 52-week data from both VELA-1 and VELA-2 studies are expected to be released in Q2 of 2026. This could be another potential comeback for ...
"Bloomberg Crypto" covers the people, transactions, and technology shaping the world of decentralized finance. Today's guests: Bitwise Head of Research Ryan Rasmussen, Solana Policy Institute President Kristin Smith, AVA Labs VP of Onchain Finance Morgan Krupetsky, and Figure Co-Founder and Executive Chair Mike Cagney. (Source: Bloomberg)
"Bloomberg Crypto" covers the people, transactions, and technology shaping the world of decentralized finance. Today's guests: Bitwise Head of Research Ryan Rasmussen, Solana Policy Institute President Kristin Smith, AVA Labs VP of Onchain Finance Morgan Krupetsky, and Figure Co-Founder and Executive Chair Mike Cagney. (Source: Bloomberg)
Gary Yeowell/DigitalVision via Getty Images I have covered Tarsus Pharmaceuticals ( TARS ) several times, highlighting the company as a Buy due to the robust growth of Xdemvy. Since my first article one year ago, the stock has risen from $47 to $75, a 60% gain that outpaced the S&P 500. In 2026, Tarsus has struggled as investors fretted about AI spending, substituting dividend-paying stocks in pla...
Gary Yeowell/DigitalVision via Getty Images I have covered Tarsus Pharmaceuticals ( TARS ) several times, highlighting the company as a Buy due to the robust growth of Xdemvy. Since my first article one year ago, the stock has risen from $47 to $75, a 60% gain that outpaced the S&P 500. In 2026, Tarsus has struggled as investors fretted about AI spending, substituting dividend-paying stocks in place of growth-oriented stocks. In this case, these fears seem unfounded, as shown by Tarsus' Q4 2025 results and 2026 guidance, demonstrating that the growth thesis has only strengthened. Tarsus remains a singular bet on Xdemvy, the first and sole FDA-approved treatment for Demodex Blepharitis (DB). DB is a highly prevalent eyelid disease that impacts approximately 25 million patients in the US. Thus, Xdemvy presents a total addressable market (TAM) that is still largely untapped. While 2025 was a breakout year, 2026 will likely be when Tarsus transitions to profitability. If so, the rally may have much further to run, given CEO Bobak Azamian's call for $2B+ in peak sales for Xdemvy. If these peak sales estimates are correct, Tarsus is still cheap because only one-third of the eventual peak sales have been achieved so far. Tarsus is now on the way to being priced as an earnings growth story instead of merely a transition to profitability. On the basis of continuing momentum for the Xdemvy commercialization, I reiterate a rating of Strong Buy for shares of Tarsus. Tarsus Q4 2025 Earnings Review CEO Bobak Azamian began the Q4 2025 earnings call highlighting Xdemvy's massive growth and strong potential. More than 500,000 patients have now taken the drug, with sales growing 128%, from $66.4M in Q4 2024 to $151.7M in Q4 2025. For FY 2025, sales grew 150%, from $180.1M in 2024 to $451.4M in 2025. Equally impressive, Tarsus guided to a mid-point of $685M in sales for 2026, or 52% YoY growth. Tarsus Selected Results* Q4 2025 Q4 2024 2026 (Guidance) FY 2025 FY 2024 Sales (millions) $...
Apple plans to start manufacturing the Mac mini in the United States later this year, the company announced today, as part of its $600 billion commitment to expand its domestic manufacturing operation. The Macs will be made in a facility in Houston, the same facility Apple uses for "advanced AI server manufacturing." CEO Tim Cook says these AI servers are shipping "ahead of schedule." The facility...
Apple plans to start manufacturing the Mac mini in the United States later this year, the company announced today, as part of its $600 billion commitment to expand its domestic manufacturing operation. The Macs will be made in a facility in Houston, the same facility Apple uses for "advanced AI server manufacturing." CEO Tim Cook says these AI servers are shipping "ahead of schedule." The facility will also eventually provide "hands-on training in advanced manufacturing techniques" for students, Apple employees, "and American businesses of all sizes." Apple and many other US tech companies have announced plans to expand their domestic manufacturing operations, just one element of a multi-prong strategy to secure favorable treatment from a Trump administration that has been happy to threaten Apple and others with steep tariffs to get what it wants. Today's Mac mini announcement is more subtle than the time Tim Cook delivered Trump a signed gold statue , but the goal is likely the same. Read full article Comments
winhorse/iStock Unreleased via Getty Images Down 40% - Finally If an American Blue-Chip stock had dropped 40% in six months, you would have most likely read headlines about it and been tempted to enter just for the sake of paying less than half a year ago. With Nintendo Co., Ltd. ( NTDOY ), on the other hand, one of the world’s leading gaming powerhouses out of Japan, lost 40% of its market value ...
winhorse/iStock Unreleased via Getty Images Down 40% - Finally If an American Blue-Chip stock had dropped 40% in six months, you would have most likely read headlines about it and been tempted to enter just for the sake of paying less than half a year ago. With Nintendo Co., Ltd. ( NTDOY ), on the other hand, one of the world’s leading gaming powerhouses out of Japan, lost 40% of its market value almost unnoticed. That is another roughly 15% since my last coverage. Despite it being one of my highest conviction long-term holdings, I have always expressed a somewhat cautious stance around the stock in recent years. Today, I am upgrading Nintendo to a personal Buy for the first time since 2022, when I started building my position. Continuing to gradually diversify away from an excessively high US concentration, Nintendo becomes another one of my 2026 top long picks—the second one out of Asia. Recap Skip this chapter if you have already read all my previous Nintendo articles. As of my first Seeking Alpha coverage in December 2023 , Switch 1 had been in the seventh year of its life cycle, and no successor console had been announced. Although R&D spending indicated that it was on the way, Nintendo saw stagnating or declining revenues and profits while milking interest income from its huge cash pile and benefiting from USD-denominated investments in a weak yen environment. Furthermore, ripple effects from the successful Super Mario Bros. Movie helped delay the Switch 1 cycle slowdown. My fair value estimate was slightly above the share price, prompting a positively inclined Hold rating. To date, Nintendo has returned 20% in USD since then, lagging the S&P 500’s 45%. Switch 2 was finally revealed in January 2025 and caused mixed feelings at first glance, while valuation had also turned less favorable, leading me to turn more cautious. Since then, the stock was essentially flat, while the S&P 500 returned 15%. Previous coverage (Seeking Alpha) Ever since then, Nintendo stock...
Booking Holdings (NASDAQ: BKNG) , the stock that has long been one of the top candidates for a stock split, just made the move. In the fourth-quarter earnings report, released Feb. 18, the online travel company announced that it was doing a 25-for-1 stock split in April. Investors have been waiting for a while for this to happen, as Booking's share price had soared to over $5,700 per share last su...
Booking Holdings (NASDAQ: BKNG) , the stock that has long been one of the top candidates for a stock split, just made the move. In the fourth-quarter earnings report, released Feb. 18, the online travel company announced that it was doing a 25-for-1 stock split in April. Investors have been waiting for a while for this to happen, as Booking's share price had soared to over $5,700 per share last summer. It has fallen sharply since then, but it is still trading at more than $4,000 per share. Image source: Getty Images. Continue reading